Department of Oncology, University of Alberta and Department of Experimental Oncology, Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, Canada.
Breast Cancer Res. 2010;12(3):R31. doi: 10.1186/bcr2583. Epub 2010 Jun 2.
A subpopulation of cancer cells, tumor-initiating cells, is believed to be the driving force behind tumorigenesis and resistance to radiation and chemotherapy. The persistence of tumor-initiating cells may depend on altered regulation of DNA damage and checkpoint proteins, as well as a reduced propensity to undergo apoptosis or senescence.
To test this hypothesis, we isolated CD24-/low/CD44+ tumor-initiating cells (as mammospheres) from MCF-7 breast cancer cells grown in adherent monolayer culture, and carried out a comprehensive comparison of cell death and DNA damage response pathways prior to and after exposure to ionizing radiation in mammospheres and monolayer MCF-7 cells. Single and double-strand break repair was measured by single-cell gel electrophoresis. The latter was also examined by phosphorylation of histone H2AX and formation of 53BP1 and Rad51 foci. Apoptosis was quantified by flow-cytometric analysis of annexin V-binding and senescence was analyzed on the basis of cellular beta-galactosidase activity. We employed the telomeric repeat amplification protocol to quantify telomerase activity. Expression of key DNA repair and cell cycle regulatory proteins was detected and quantified by western blot analysis.
Our data demonstrate that in comparison to the bulk population of MCF-7 cells (predominantly CD24+/CD44+), the MCF-7 mammosphere cells benefit from a multifaceted approach to cellular protection relative to that seen in monolayer cells, including a reduced level of reactive oxygen species, a more active DNA single-strand break repair (SSBR) pathway, possibly due to a higher level of expression of the key SSBR protein, human AP endonuclease 1 (Ape1), and a significantly reduced propensity to undergo senescence as a result of increased telomerase activity and a low level of p21 protein expression. No significant difference was seen in the rates of double-strand break repair (DSBR) between the two cell types, but DSBR in mammospheres appears to by-pass the need for H2AX phosphorylation.
Enhanced survival of MCF-7 tumor-initiating cells in response to ionizing radiation is primarily dependent on an inherent down-regulation of the senescence pathway. Since MCF-7 cells are representative of cancer cells that do not readily undergo apoptosis, consideration of senescence pathways may play a role in targeting stem cells from such tumors.
肿瘤起始细胞是癌细胞的一个亚群,被认为是肿瘤发生和对辐射及化疗耐药的驱动力。肿瘤起始细胞的持续存在可能依赖于 DNA 损伤和检查点蛋白的改变调节,以及降低细胞凋亡或衰老的倾向。
为了验证这一假说,我们从在贴壁单层培养中生长的 MCF-7 乳腺癌细胞中分离出 CD24-/low/CD44+肿瘤起始细胞(作为类乳腺球体),并在类乳腺球体和单层 MCF-7 细胞中进行了电离辐射暴露前后细胞死亡和 DNA 损伤反应途径的全面比较。单细胞凝胶电泳法测量单链和双链断裂修复。后者也通过组蛋白 H2AX 的磷酸化和 53BP1 和 Rad51 焦点的形成来检测。通过流式细胞术分析 Annexin V 结合来定量细胞凋亡,通过细胞β-半乳糖苷酶活性分析来分析衰老。我们采用端粒重复扩增协议来定量端粒酶活性。通过 Western blot 分析检测和定量关键 DNA 修复和细胞周期调节蛋白的表达。
与 MCF-7 细胞的大部分群体(主要为 CD24+/CD44+)相比,我们的数据表明,MCF-7 类乳腺球体细胞相对于单层细胞具有多种细胞保护途径,包括活性氧水平降低、更活跃的 DNA 单链断裂修复(SSBR)途径,可能是由于关键 SSBR 蛋白人 APE1 的表达水平更高,以及由于端粒酶活性增加和 p21 蛋白表达水平降低而导致衰老的倾向降低。两种细胞类型之间的双链断裂修复(DSBR)率没有明显差异,但类乳腺球体中的 DSBR 似乎绕过了 H2AX 磷酸化的需要。
MCF-7 肿瘤起始细胞对电离辐射的存活增强主要依赖于衰老途径的固有下调。由于 MCF-7 细胞代表不易发生细胞凋亡的癌细胞,因此考虑衰老途径可能在靶向此类肿瘤的干细胞中发挥作用。